The Healthcare Investor

Latest from The Healthcare Investor - Page 26

The physician practice management (PPM) arena is a mixture of tailwinds, including the ability to expand ancillary services, and headwinds, including more expensive labor costs and antitrust pressures.

On this episode of The Corner Series, McGuireWoods’ Geoff Cockrell speaks with Andrew Colbert, senior managing director at Ziegler, a privately held investment bank, capital

Coalesce Capital has announced the closing of its inaugural fund with more than $900 million in commitments.

The fund, Coalesce Capital Fund I, was oversubscribed, exceeding its $750 million initial target.

Coalesce, based in New York, is a middle market private equity firm focused on investing in human capital and technology-enabled business services companies. The firm primarily

Argosy Healthcare Partners (AHP) has announced the recapitalization of Command Medical Products.

Command, based in Ormond Beach, Fla., and founded in 1987, provides contract manufacturing services for medical devices sold by original equipment manufacturers and other device providers. 

AHP, based in Wayne, Pa., is a lower middle market private equity investor focused exclusively

The regulatory landscape for telehealth prescribing of controlled substances is evolving.

In episode 13 of Complications: Health Policy Unraveled, host Stephanie Kennan covers the DEA’s recent extension of pandemic-era telehealth prescribing flexibilities for controlled substances through 2024, marking the second extension. Originally set to expire in May, these extensions followed extensive public input, including 38,000